Direxion Daily S&P Biotech Bull 3X Shares
LABU
LABU
41 hedge funds and large institutions have $84.4M invested in Direxion Daily S&P Biotech Bull 3X Shares in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 1 increasing their positions, 22 reducing their positions, and 23 closing their positions.
Holders
41
Holders Change
-7
Holders Change %
-14.58%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
1
Reduced
22
Closed
23
Calls
$246M
Puts
$93.4M
Net Calls
+$153M
Net Calls Change
+$156M
Top Buyers
| 1 |
1
Barclays
London,
United Kingdom
|
$18.5M |
| 2 |
2
Jane Street
New York
|
$9.92M |
| 3 |
3
Group One Trading
Chicago,
Illinois
|
$2.25M |
| 4 |
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.84M |
| 5 |
5
Goldman Sachs
New York
|
$1.19M |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$10.6M |
| 2 |
2
Squarepoint
New York
|
$7.47M |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$3.55M |
| 4 |
GS
4
GTS Securities
New York
|
$3.26M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$3.43M |
